An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2016
At a glance
- Drugs Vibegron (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- 07 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Dec 2012 Planned End Date changed from 1 Dec 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.